API
< Back to all clusters
[BUSINESS] · South Korea, United States · 3 sources

started · updated

SK Biopharm launches LinX platform to support Korean biotech in US

SK Biopharm has selected 31 domestic pharmaceutical and biotech companies to participate in LinX, an open innovation platform designed to facilitate entry into the United States market. Operating out of the SK Life Science office, the platform provides infrastructure, including office and meeting spaces, to help Asian companies expand their networks and discover business opportunities in North America.

In collaboration with KOTRA and the Korean American Society for Pharmaceutical and Bio Industries (KASBP), the program offers specialized support in areas such as FDA regulatory affairs, clinical trials, intellectual property strategy, and business development. SK Biopharm intends to share its practical expertise gained from the development, FDA approval, and commercialization of its drug, Cenobamate.

This initiative aims to serve as an ‘East-West Bridge,’ connecting Asian technological capabilities with the US market through technical pitching, investor networking, and professional consulting services.

Entities

FDA · KASBP · KOTRA · SK Biopharm · SK Life Science